Aziyo Biologics Inc logo

Aziyo Biologics Inc

$ 3.61 -0.395 (-9.88%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 49.66M
Enterprise V:
$ 74.75M
Volume:
191.38K
Avg Vol (2M):
20.50K
Volume:
191.38K
Market Cap $:
49.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
20.50K
Enterprise Value $:
74.75M
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.29
Equity-to-Asset -0.18
Debt-to-Equity -2.6
Debt-to-EBITDA -1
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.47
Distress
Grey
Safe
Beneish M-Score -0.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 4.05
9-Day RSI 9.3
14-Day RSI 16.31
6-1 Month Momentum % 26.75
12-1 Month Momentum % 92.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.09
Quick Ratio 0.83
Cash Ratio 0.2
Days Inventory 120.52
Days Sales Outstanding 48.27
Days Payable 22.98

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29
Name Current Vs Industry Vs History
Gross Margin % 37.18
Operating Margin % -62.07
Net Margin % -77.08
ROE % -1149.25
ROA % -60.69
ROIC % -78.38
ROC (Joel Greenblatt) % -775.61
ROCE % -104.78

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.98
EV-to-EBIT -2.36
EV-to-EBITDA -2.67
EV-to-Revenue 1.56
EV-to-FCF -3.25
Earnings Yield (Greenblatt) % -42.37

Financials (Next Earnings Date:2023-03-03 Est.)

AZYO's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:AZYO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 47.383
EPS (TTM) ($) -2.84
Beta 0
Volatility % 52.17
14-Day RSI 16.31
14-Day ATR ($) 0.714603
20-Day SMA ($) 7.11187
12-1 Month Momentum % 92.22
52-Week Range ($) 3.55 - 9.01
Shares Outstanding (Mil) 13.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aziyo Biologics Inc Filings

Document Form Filing Date
No Filing Data

Aziyo Biologics Inc Analysis

Share your research

Headlines

See More
No news.